Insulin-like growth factor binding protein-4 as a marker of chronic lupus nephritis

Tianfu Wu, Chun Xie, Jie Han, Yujin Ye, Sandeep Singh, Jinchun Zhou, Yajuan Li, Huihua Ding, Quan Zhen Li, Xin Zhou, Chaim Putterman, Ramesh Saxena, Chandra Mohan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Kidney biopsy remains the mainstay of Lupus Nephritis (LN) diagnosis and prognostication. The objective of this study is to identify non-invasive biomarkers that closely parallel renal pathology in LN. Previous reports have demonstrated that serum Insulin-like growth factor binding protein 4 (IGFBP-4) was increased in diabetic nephropathy in both animal models and patients. We proceeded to assess if IGFBP4 could be associated with LN. We performed ELISA using the serum of 86 patients with LN. Normal healthy adults (N = 23) and patients with other glomerular diseases (N = 20) served as controls. Compared to the healthy controls or other glomerular disease controls, serum IGFBP-4 levels were significantly higher in the patients with LN. Serum IGFBP-4 did not correlate well with systemic lupus erythematosus disease activity index (SLEDAI), renal SLEDAI or proteinuria, but it did correlate with estimated glomerular filtration rate (R = 0.609, P <0.0001). Interestingly, in 18 patients with proliferative LN whose blood samples were obtained at the time of renal biopsy, serum IGFBP-4 levels correlated strongly with the chronicity index of renal pathology (R = 0.713, P <0.001). IGFBP-4 emerges a potential marker of lupus nephritis, reflective of renal pathology chronicity changes.

Original languageEnglish (US)
Article numbere0151491
JournalPLoS One
Volume11
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Insulin-Like Growth Factor Binding Protein 4
nephritis
Lupus Nephritis
insulin-like growth factor binding proteins
Pathology
kidneys
Kidney
blood proteins
Biopsy
lupus erythematosus
Serum
Disease control
Systemic Lupus Erythematosus
biopsy
Biomarkers
diabetic nephropathy
glomerular filtration rate
Animals
Blood
Diabetic Nephropathies

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Wu, T., Xie, C., Han, J., Ye, Y., Singh, S., Zhou, J., ... Mohan, C. (2016). Insulin-like growth factor binding protein-4 as a marker of chronic lupus nephritis. PLoS One, 11(3), [e0151491]. https://doi.org/10.1371/journal.pone.0151491

Insulin-like growth factor binding protein-4 as a marker of chronic lupus nephritis. / Wu, Tianfu; Xie, Chun; Han, Jie; Ye, Yujin; Singh, Sandeep; Zhou, Jinchun; Li, Yajuan; Ding, Huihua; Li, Quan Zhen; Zhou, Xin; Putterman, Chaim; Saxena, Ramesh; Mohan, Chandra.

In: PLoS One, Vol. 11, No. 3, e0151491, 01.03.2016.

Research output: Contribution to journalArticle

Wu, T, Xie, C, Han, J, Ye, Y, Singh, S, Zhou, J, Li, Y, Ding, H, Li, QZ, Zhou, X, Putterman, C, Saxena, R & Mohan, C 2016, 'Insulin-like growth factor binding protein-4 as a marker of chronic lupus nephritis', PLoS One, vol. 11, no. 3, e0151491. https://doi.org/10.1371/journal.pone.0151491
Wu, Tianfu ; Xie, Chun ; Han, Jie ; Ye, Yujin ; Singh, Sandeep ; Zhou, Jinchun ; Li, Yajuan ; Ding, Huihua ; Li, Quan Zhen ; Zhou, Xin ; Putterman, Chaim ; Saxena, Ramesh ; Mohan, Chandra. / Insulin-like growth factor binding protein-4 as a marker of chronic lupus nephritis. In: PLoS One. 2016 ; Vol. 11, No. 3.
@article{13e9e832e6314b9f81ea41ecd1e8a5c5,
title = "Insulin-like growth factor binding protein-4 as a marker of chronic lupus nephritis",
abstract = "Kidney biopsy remains the mainstay of Lupus Nephritis (LN) diagnosis and prognostication. The objective of this study is to identify non-invasive biomarkers that closely parallel renal pathology in LN. Previous reports have demonstrated that serum Insulin-like growth factor binding protein 4 (IGFBP-4) was increased in diabetic nephropathy in both animal models and patients. We proceeded to assess if IGFBP4 could be associated with LN. We performed ELISA using the serum of 86 patients with LN. Normal healthy adults (N = 23) and patients with other glomerular diseases (N = 20) served as controls. Compared to the healthy controls or other glomerular disease controls, serum IGFBP-4 levels were significantly higher in the patients with LN. Serum IGFBP-4 did not correlate well with systemic lupus erythematosus disease activity index (SLEDAI), renal SLEDAI or proteinuria, but it did correlate with estimated glomerular filtration rate (R = 0.609, P <0.0001). Interestingly, in 18 patients with proliferative LN whose blood samples were obtained at the time of renal biopsy, serum IGFBP-4 levels correlated strongly with the chronicity index of renal pathology (R = 0.713, P <0.001). IGFBP-4 emerges a potential marker of lupus nephritis, reflective of renal pathology chronicity changes.",
author = "Tianfu Wu and Chun Xie and Jie Han and Yujin Ye and Sandeep Singh and Jinchun Zhou and Yajuan Li and Huihua Ding and Li, {Quan Zhen} and Xin Zhou and Chaim Putterman and Ramesh Saxena and Chandra Mohan",
year = "2016",
month = "3",
day = "1",
doi = "10.1371/journal.pone.0151491",
language = "English (US)",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - Insulin-like growth factor binding protein-4 as a marker of chronic lupus nephritis

AU - Wu, Tianfu

AU - Xie, Chun

AU - Han, Jie

AU - Ye, Yujin

AU - Singh, Sandeep

AU - Zhou, Jinchun

AU - Li, Yajuan

AU - Ding, Huihua

AU - Li, Quan Zhen

AU - Zhou, Xin

AU - Putterman, Chaim

AU - Saxena, Ramesh

AU - Mohan, Chandra

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Kidney biopsy remains the mainstay of Lupus Nephritis (LN) diagnosis and prognostication. The objective of this study is to identify non-invasive biomarkers that closely parallel renal pathology in LN. Previous reports have demonstrated that serum Insulin-like growth factor binding protein 4 (IGFBP-4) was increased in diabetic nephropathy in both animal models and patients. We proceeded to assess if IGFBP4 could be associated with LN. We performed ELISA using the serum of 86 patients with LN. Normal healthy adults (N = 23) and patients with other glomerular diseases (N = 20) served as controls. Compared to the healthy controls or other glomerular disease controls, serum IGFBP-4 levels were significantly higher in the patients with LN. Serum IGFBP-4 did not correlate well with systemic lupus erythematosus disease activity index (SLEDAI), renal SLEDAI or proteinuria, but it did correlate with estimated glomerular filtration rate (R = 0.609, P <0.0001). Interestingly, in 18 patients with proliferative LN whose blood samples were obtained at the time of renal biopsy, serum IGFBP-4 levels correlated strongly with the chronicity index of renal pathology (R = 0.713, P <0.001). IGFBP-4 emerges a potential marker of lupus nephritis, reflective of renal pathology chronicity changes.

AB - Kidney biopsy remains the mainstay of Lupus Nephritis (LN) diagnosis and prognostication. The objective of this study is to identify non-invasive biomarkers that closely parallel renal pathology in LN. Previous reports have demonstrated that serum Insulin-like growth factor binding protein 4 (IGFBP-4) was increased in diabetic nephropathy in both animal models and patients. We proceeded to assess if IGFBP4 could be associated with LN. We performed ELISA using the serum of 86 patients with LN. Normal healthy adults (N = 23) and patients with other glomerular diseases (N = 20) served as controls. Compared to the healthy controls or other glomerular disease controls, serum IGFBP-4 levels were significantly higher in the patients with LN. Serum IGFBP-4 did not correlate well with systemic lupus erythematosus disease activity index (SLEDAI), renal SLEDAI or proteinuria, but it did correlate with estimated glomerular filtration rate (R = 0.609, P <0.0001). Interestingly, in 18 patients with proliferative LN whose blood samples were obtained at the time of renal biopsy, serum IGFBP-4 levels correlated strongly with the chronicity index of renal pathology (R = 0.713, P <0.001). IGFBP-4 emerges a potential marker of lupus nephritis, reflective of renal pathology chronicity changes.

UR - http://www.scopus.com/inward/record.url?scp=84962360696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962360696&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0151491

DO - 10.1371/journal.pone.0151491

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 3

M1 - e0151491

ER -